4.8 Article

Malaria Elimination 4 Costs and financial feasibility of malaria elimination

Journal

LANCET
Volume 376, Issue 9752, Pages 1604-1615

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(10)61355-4

Keywords

-

Funding

  1. Bill & Melinda Gates Foundation
  2. ExxonMobil
  3. NIH/NCRR UCSF-CTSI [UL1 RR024131]

Ask authors/readers for more resources

The marginal costs and benefits of converting malaria programmes from a control to an elimination goal are central to strategic decisions, but empirical evidence is scarce. We present a conceptual framework to assess the economics of elimination and analyse a central component of that framework potential short-term to medium-term financial savings. After a review that showed a dearth of existing evidence, the net present value of elimination in five sites was calculated and compared with effective control. The probability that elimination would be cost-saving over SO years ranged from 0% to 42%, with only one site achieving cost-savings in the base case. These findings show that financial savings should not be a primary rationale for elimination, but that elimination might still be a worthy investment if total benefits are sufficient to outweigh marginal costs. Robust research into these elimination benefits is urgently needed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available